Figure 1From: Morning versus evening dosing of desloratadine in seasonal allergic rhinitis: a randomized controlled study [ISRCTN23032971].Symptom scores. Total and individual symptom scores at baseline and over two weeks treatment period Baseline: ○ AM-group; Δ PM-group, Treatment: ● AM-group; ▲ PM-group 1 Max score = 12, 2 Max score = 3Back to article page